Skip to content
Screener

QuidelOrtho Corporation QDEL Free cash flow margin

Discontinued — last reported Q1 '23

Free cash flow margin at other companies

Abbott logo
AbbottABT
16.8%+1.1pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
13.8%-0.2pp
Danaher logo
DanaherDHR
21.8%+1.5pp
OraSure Technologies logo
OraSure TechnologiesOSUR
-42.8%-85.7pp
Revvity logo
RevvityRVTY
17%-1.9pp
Opko Health logo
Opko HealthOPK
-22.8%-6.7pp

Other financials

Income statement

See full
Revenue$630.9M+2.8%
Gross profit$272.9M-0.7%
Operating income-$21.8M+87.9%
Net income-$92.9M+63.6%
EPS (diluted)-$1.36+63.9%

Balance sheet

See full
Cash & equivalents$123.4M-18.7%
Total debt$3.4B+3.0%
Total equity$1.8B-36.4%
Total assets$5.7B-10.4%

Cash flow

See full
Operating cash flow-$110.6M—
CapEx$25.5M-32.0%
Free cash flow-$136.1M-61.4%

Valuation

See full
Market cap$1.11B-30.1%
Enterprise value$4.42B-7.4%
P/S0.4×-0.2×

Profitability

See full
Gross margin44.6%-2.7pp
Operating margin-30.8%-49.9pp
Net margin-39.2%-168pp

Returns & leverage

See full
Return on equity-45.9%-94.9pp
Debt / equity1.9×+0.7×
Current ratio1.4×+0.3×

Where this comes from

Calculated from QuidelOrtho Corporation’s reported figures.

free cash flow/total revenue=13.8%

Based on trailing twelve months.

The source filing: QuidelOrtho Corporation’s 10-Q, filed May 9, 2024. Open the filing →

Filed
May 9, 2024
Fiscal quarter
Q1 FY2024
Calendar quarter
Q2 2024
Accession
0001906324-24-000032

FAQ

What is QuidelOrtho Corporation's free cash flow margin?
QuidelOrtho Corporation (QDEL) reported free cash flow margin of 13.8% in Q1 2023.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Ask your AI about QuidelOrtho Corporation's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude